Cargando…

Use of rituximab in glomerulopathies

Detalles Bibliográficos
Autores principales: Dias, Cristiane Bitencourt, Woronik, Viktoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Nefrologia 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9269178/
https://www.ncbi.nlm.nih.gov/pubmed/35201257
http://dx.doi.org/10.1590/2175-8239-JBN-2022-E004
_version_ 1784744169532555264
author Dias, Cristiane Bitencourt
Woronik, Viktoria
author_facet Dias, Cristiane Bitencourt
Woronik, Viktoria
author_sort Dias, Cristiane Bitencourt
collection PubMed
description
format Online
Article
Text
id pubmed-9269178
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Sociedade Brasileira de Nefrologia
record_format MEDLINE/PubMed
spelling pubmed-92691782022-07-20 Use of rituximab in glomerulopathies Dias, Cristiane Bitencourt Woronik, Viktoria J Bras Nefrol Editorial Sociedade Brasileira de Nefrologia 2022-02-23 2022 /pmc/articles/PMC9269178/ /pubmed/35201257 http://dx.doi.org/10.1590/2175-8239-JBN-2022-E004 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Dias, Cristiane Bitencourt
Woronik, Viktoria
Use of rituximab in glomerulopathies
title Use of rituximab in glomerulopathies
title_full Use of rituximab in glomerulopathies
title_fullStr Use of rituximab in glomerulopathies
title_full_unstemmed Use of rituximab in glomerulopathies
title_short Use of rituximab in glomerulopathies
title_sort use of rituximab in glomerulopathies
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9269178/
https://www.ncbi.nlm.nih.gov/pubmed/35201257
http://dx.doi.org/10.1590/2175-8239-JBN-2022-E004
work_keys_str_mv AT diascristianebitencourt useofrituximabinglomerulopathies
AT woronikviktoria useofrituximabinglomerulopathies